You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 628 Circulatory plasma proteomic biomarkers combined with high-throughput proteomic screen of patient-derived organotypic tumor spheroids predict responses to immunotherapy in melanoma patients

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial Completed
628 Circulatory plasma proteomic biomarkers combined with high-throughput proteomic screen of patient-derived organotypic tumor spheroids predict responses to immunotherapy in melanoma patients

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023208011
Dec 20234803
Jan 20242502
Feb 20243201
Mar 20244004
Apr 20244002
May 20241800
Jun 20241402
Jul 20241001
Aug 2024600
Sep 20241802
Oct 20241203
Nov 20243002
Dec 2024804
Jan 20251606
Feb 2025103
Mar 2025007
Apr 2025002
May 2025002
Jun 2025003
Total526060